PharmaCyte Biotech Inc (PMCB): Don't mean to be picky but I would have...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	9
Posts	257
Boards Moderated	0
Alias Born	06/12/2015

Mens et Manus

Re: None

Friday, 10/20/2017 9:31:04 AM

Friday, October 20, 2017 9:31:04 AM

Don't mean to be picky but I would have done the cc on October 31st just to meet the October time frame mentioned on the Facebook page. Once again, the CEO never meets a date. LOL!!!!

I would rather this be written as the CEO is not very good on cc calls.
He is going to briefly cover diabetes. How can you do that. I think it has been 2 years since we have any updates at all. God help us!!!!

Why has it taken over 9 months from meeting with the FDA and still no IND.
Inexcusable!!!!!!!

LAGUNA HILLS, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it will be meeting with the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) on Tuesday, January 17, 2017. The meeting is to discuss numerous aspects of PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer (LAPC).